• Research Topics

  FightMND Awards Clene $9.3M to Advance CNM-Au8 Clinical Trials in ALS

  Posted by ALS News Today Moderator on September 25, 2019 at 7:17 am

  

  FightMND has awarded Clene about $9.3M to support the launch of a Phase 2 clinical study in Australia exploring CNM-Au8 as treatment for ALS. Read more here.

  What do you think of this news?

  ALS News Today Moderator replied 4 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply